Jordyn Silverstein, Medical Gynecologic Oncologist and Researcher at UCLA, shared a post on X:
“There’s hope in platinum resistant ovarian cancer – more work to be done – but three positive trials that improve overall survival – after decades without real progress. Coming into gynecologic oncology at an exciting rapidly changing time.
Keynote B96 – pembro + paclitaxel
Rosella – relacorilant + nab-paclitaxel
MIRASOL – Mirveuximab.”
More posts about Ovarian Cancer.